Eric Chen
Managing Partner @ SoftBank Vision Fund
San Francisco, United States
Eric Chen is a seed investor at SoftBank Vision Fund in San Francisco focused on E-Commerce and Artificial Intelligence. Eric Chen joined Silver Lake in 2008 and is a Managing Director. Prior to Silver Lake, Dr. Chen was a Senior Vice President and Executive Committee member of ASML, a global leader in semiconductor technology. Dr. Chen joined ASML following its acquisition of Brion Technologies in 2007, the company he co-founded in 2002 and served as the CEO sinceinception. He was formerly a Senior Vice President at J.P. Morgan, where he coordinated the global research effort in the electronics sector and conducted equity research for a number of technology segments. Earlier in his career, Dr. Chen conducted theoretical physics research at Conseil Européen pour la Recherche Nucléaire ("CERN") and at the Advanced Product Research Development Laboratory and MOS-13 facility for Motorola. Dr. Chen is currently on the board of Allyes Online Media Holding and Hillstone Networks. Previously, he served on the boards of Nobao Renewable Energy Holdings Limited and Varian Semiconductor. Dr. Chen was born and raised in China and is bilingual in English and Chinese (Mandarin). He represented China in the International Physics Olympics in Germany, earning the Silver Medal. Dr. Chen studied Physics at Peking University and received his Ph.D. in Electrical Engineering from Stanford University.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 54%
Last updated:
For AI agents: llms.txt
Industries Eric Chen invests in
Stages Eric Chen invests in
Countries Eric Chen invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $800k–$1.5M
- Series A
- $1M–$2M
- Series C
- $50M–$319M
Investment Focus
Industry
- E-Commerce 4 (31%)
- Artificial Intelligence 3 (23%)
- Travel 2 (15%)
- Big Data 2 (15%)
- Internet 2 (15%)
Stage
- Seed 4 (31%)
- Series C 3 (23%)
- Series A 2 (15%)
- Series D 1 (8%)
- Series E 1 (8%)
Country
- United States 8 (62%)
- China 1 (8%)
- Canada 1 (8%)
- Singapore 1 (8%)
- United Kingdom 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CORMANI is a high performance computing (HPC) company that increases compute performance significantly, made possible by the development of its breakthrough and patented multi-core technology that efficiently uses heterogeneous cores in a highly concurrent, parallel manner. This technology will reduce the use of power sources and lower latency,while vastly increasing the compute performance of products and their ROI in a variety of markets, with the Company’s initial focus being Big Data. | $68M / Series C / Mar 01, 2022 | ||
| Shoplazza is an award-winning shopping cart commerce technology company that provides differentiated value by offering technology that is easy to start, market and manage online stores of any size. The single integrated back-end platform powered by advanced data analytical capability is engineered for reliability, security and adaptivity, ensuringour merchants never miss a turn.Shoplazza champions merchants to not only build an online store but own their brand. The North America-based Direct-to-customer (“DTC”) branding incubation team provides service covering the entire journey of buyers that helps merchants develop a direct relationship with the buyers and make their brand memorable and distinctive.The company was founded in 2017 and with our global strategy department headquartered in Toronto. | $150M / Series C / Jan 20, 2022 | ||
| CORMANI is a high performance computing (HPC) company that increases compute performance significantly, made possible by the development of its breakthrough and patented multi-core technology that efficiently uses heterogeneous cores in a highly concurrent, parallel manner. This technology will reduce the use of power sources and lower latency,while vastly increasing the compute performance of products and their ROI in a variety of markets, with the Company’s initial focus being Big Data. | $50M / Series C / Oct 07, 2021 | ||
| Exscientia combines human expertise with AI and machine learning to enhance drug discovery. The company focuses on precision engineering of medicine candidates, enabling faster and more efficient development of new treatments. By integrating innovative experimental techniques, Exscientia aims to improve patient outcomes and revolutionize thepharmaceutical industry. | $225M / Series D / Apr 20, 2021 | ||
| PatSnap is a connected innovation intelligence platform that provides IP and R&D intelligence. It is used by more than 10,000 customers in over 50 countries around the world to access market, technology, and competitive intelligence as well as patent insights needed to take products from ideation to commercialization. The company was foundedin 2007 and is headquartered in Singapore. | $300M / Series E / Mar 16, 2021 | ||
| Keep is a young team that loves sports and is also a group of Geeks who pursue the ultimate experience. They focus on application development in the field of mobile sports, advocate the spirit of open sharing, do not imitate, do not follow suit, and only do cool products.In the age of their lives, the fitness culture is awakening, there should bemore professional tools, a more pure community, and make the body easier. This is what Keep is doing. They hope that through technology-driven, more people will love fitness and enjoy sports. | $360M / Series F / Jan 10, 2021 | ||
| XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enablespharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies. | $318.8M / Series C / Sep 28, 2020 | ||
| ZingBox is a U.S.-based company that provides security for Internet of Things infrastructure. It is based in Mountain View, California. | $1.5M / Seed / Dec 12, 2014 | ||
| With a few pictures and a description of an item you wish to sell, Sold will price the item, sell it, handle the shipping, and deposit the customers funds directly into their bank account. | Seed / Jun 01, 2012 | ||
| Triptrotting is a venture backed travel company that matches travelers and locals based on similar interests. It is an online community and its application “Wist” helps its users feel like locals anywhere they go, whether in an unknown neighborhood in their own city or far away land.This new application of Triptrotting uses a combination ofcontextual, personalized, and social data to create unique and most relevant recommendations for every user.Triptrotting is headquartered in San Francisco, C.A. with additional offices in New York, Los Angeles, Miami, Washington D.C., Boston, and Chicago. It was founded in 2011. | $1M / Series A / Mar 08, 2012 | ||
| See all 13 investments → | |||
Co-Investors
About SoftBank Vision Fund
SoftBank Vision Fund is a subsidiary of Softbank Group that specializes in growth capital and social impact investments. Sectors that the fund invests in include the internet of things, artificial intelligence (AI), robotics, communications infrastructure, telecoms, computational biology, biotech, cloud technologies and software, consumer internetbusinesses, financial technology, and mobile apps. The Fund is designed to be a catalyst for technology progress in anticipation that it will expand SoftBank's capabilities, accelerating progress towards SoftBank 2.0.It aims to invest in businesses and foundational platforms that SoftBank believes to revolutionize and innovate the world tomorrow.
SoftBank Vision Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Colin Fan
Managing Partner, Americas, Asia
|
|||
David Thevenon
Partner
|
|||
Javier Villamizar
Partner, Joint Ventures and Portfolio Synergies
|
|||
Sumer Juneja
Partner and Head of India
|
|||
Akshay Naheta
Partner, EMEA
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Eric Chen invest in?
Eric Chen invests primarily in E-Commerce, Artificial Intelligence and Travel startups, most often at Seed and Series C stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Eric Chen's check size?
Eric Chen typically joins rounds of $800k–$1.5M at Seed, $1M–$2M at Series A and $50M–$319M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Eric Chen participates in.
How do I contact Eric Chen?
Public channels for Eric Chen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Eric Chen last invest?
The most recent investment recorded for Eric Chen closed in Mar 2022. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
